1
|
Thapa A, Cowell A, Peters A, Noble DJ, James A, Lamb C, Grose D, Vohra S, Schipani S, Mactier K, Mackenzie J, Srinivasan D, Laws K, Moleron R, Niblock P, Soh FY, Paterson C, Wilson C. The UK Divide: Does Having a Pembrolizumab-Chemotherapy Option in Head and Neck Cancer Matter? Real-world Experience of First-line Palliative Pembrolizumab Monotherapy and Pembrolizumab-Chemotherapy Combination in Scotland. Clin Oncol (R Coll Radiol) 2024; 36:287-299. [PMID: 38395634 DOI: 10.1016/j.clon.2024.02.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2023] [Revised: 12/21/2023] [Accepted: 02/08/2024] [Indexed: 02/25/2024]
Abstract
AIMS The Scottish Medical Consortium recently approved first-line pembrolizumab monotherapy or in combination with chemotherapy for head and neck squamous cell carcinoma in the palliative setting, contrasting with the decision made by the National Institute for Health and Care Excellence, who approved monotherapy alone in England and Wales. The aim of this study was to provide real-world performance data for first-line pembrolizumab-containing treatments for head and neck squamous cell carcinoma in the palliative setting in Scotland. MATERIALS AND METHODS We analysed the electronic records of patients who started pembrolizumab-containing treatment between 1 March 2020 and 30 September 2021. Outcomes included overall survival, progression-free survival (PFS), the duration of response and the disease control rate. Data were compared with the KEYNOTE-048 study and clinical factors were evaluated for association with survival. RESULTS Our cohort included 91 patients (median follow-up 10.8 months). Patient characteristics were similar to those in the KEYNOTE-048 study, although our cohort had a higher proportion of patients with newly diagnosed, non-metastatic disease. For patients receiving monotherapy (n = 76), 12- and 24-month overall survival were 45% and 27%, respectively. For patients receiving pembrolizumab-chemotherapy (n = 15), 12-month overall survival was 60% (24-month overall survival had not yet been reached). Experiencing one or more immune-related adverse event (irAE; versus no irAEs), of any grade, was associated with favourable overall survival and PFS for patients receiving monotherapy in both univariable Log-rank analysis (median overall survival 17.4 months versus 8.6 months, respectively, P = 0.0033; median PFS 10.9 months versus 3.0 months, respectively, P < 0.0001) and multivariable analysis (Cox proportional hazards regression: overall survival hazard ratio 0.31, P = 0.0009; PFS hazard ratio 0.17, P < 0.0001). CONCLUSION Our real-world data support the KEYNOTE-048 study findings and the value of combination treatment options. Additionally, our data show that irAEs of any grade, as reported in routine clinical records, are associated with better outcomes in this patient group, adding to the growing body of evidence showing that irAEs are generally a positive marker of programmed death-ligand 1 (PD-L1) inhibitor response.
Collapse
Affiliation(s)
- A Thapa
- College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK
| | - A Cowell
- Beatson West of Scotland Cancer Centre, Glasgow, UK
| | - A Peters
- Beatson West of Scotland Cancer Centre, Glasgow, UK
| | - D J Noble
- Department of Clinical Oncology, Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK; Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK
| | - A James
- Beatson West of Scotland Cancer Centre, Glasgow, UK
| | - C Lamb
- Beatson West of Scotland Cancer Centre, Glasgow, UK
| | - D Grose
- Beatson West of Scotland Cancer Centre, Glasgow, UK
| | - S Vohra
- Beatson West of Scotland Cancer Centre, Glasgow, UK
| | - S Schipani
- Beatson West of Scotland Cancer Centre, Glasgow, UK
| | - K Mactier
- Department of Clinical Oncology, Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK
| | - J Mackenzie
- Department of Clinical Oncology, Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK
| | - D Srinivasan
- Department of Clinical Oncology, Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK
| | - K Laws
- Aberdeen Royal Infirmary, Aberdeen, UK
| | - R Moleron
- Aberdeen Royal Infirmary, Aberdeen, UK
| | | | - F-Y Soh
- Raigmore Hospital, Inverness, UK
| | - C Paterson
- Beatson West of Scotland Cancer Centre, Glasgow, UK.
| | - C Wilson
- Beatson West of Scotland Cancer Centre, Glasgow, UK.
| |
Collapse
|
2
|
Mackenzie G, Summers D, Mackenzie J, Knight R. Diagnostic accuracy of diffusion-weighted imaging in variant Creutzfeldt-Jakob disease. Neuroradiology 2023; 65:1715-1727. [PMID: 37831099 PMCID: PMC10654212 DOI: 10.1007/s00234-023-03230-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2023] [Accepted: 09/28/2023] [Indexed: 10/14/2023]
Abstract
PURPOSE This study sought to investigate the diagnostic sensitivity of diffusion-weighted imaging (DWI) in variant Creutzfeldt-Jakob disease (vCJD), a prion disease with significant public health implications on account of its transmissibility. The importance of this research stemmed from the first neuropathologically confirmed vCJD case in a PRNP heterozygous individual in 2016, which displayed DWI features typical of sporadic CJD (sCJD). The case was classified as 'probable' sCJD in life, predominantly based on these imaging findings. While DWI has proven valuable in diagnosing sCJD, its utility in vCJD diagnosis remains unclear. METHODS DWI and Fluid-attenuated inversion recovery (FLAIR) images from probable and definite vCJD cases referred to the National CJD Research and Surveillance Unit (NCJDRSU) were independently analysed by an expert neuroradiologist. Scans were reviewed within a mixed cohort of CJD cases including definite sCJD and non-CJD controls. RESULTS FLAIR sequences demonstrated greater sensitivity in identifying the pulvinar sign in vCJD compared to DWI (73% vs 41%, p-value <0.001). Basal ganglia hyperintensities were more prevalent in DWI (84%) than FLAIR (64%), and cortical hyperintensities were exclusive to DWI (24%). The pulvinar sign showed a specificity of 98% for vCJD and was rare in sCJD. CONCLUSION DWI showed reduced sensitivity compared to FLAIR imaging in detecting the pulvinar sign in vCJD. Conversely, DWI can more distinctively identify basal ganglia and cortical hyperintensities, thus leading to imaging patterns more characteristic of sCJD. Therefore, DWI should be cautiously interpreted in vCJD diagnosis, with axial FLAIR potentially providing a more precise evaluation of the pulvinar sign.
Collapse
Affiliation(s)
- G Mackenzie
- National CJD Research and Surveillance Unit, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
| | - D Summers
- Department of Neuroradiology, Royal Infirmary of Edinburgh, Edinburgh, UK
| | - J Mackenzie
- National CJD Research and Surveillance Unit, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK
| | - R Knight
- National CJD Research and Surveillance Unit, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK
| |
Collapse
|
3
|
Speck P, Mackenzie J, Bull RA, Slobedman B, Drummer H, Fraser J, Herrero L, Helbig K, Londrigan S, Moseley G, Prow N, Hansman G, Edwards R, Ahlenstiel C, Abendroth A, Tscharke D, Hobson-Peters J, Kriiger-Loterio R, Parry R, Marsh G, Harding E, Jacques DA, Gartner MJ, Lee WS, McAuley J, Vaz P, Sainsbury F, Tate MD, Sinclair J, Imrie A, Rawlinson S, Harman A, Carr JM, Monson EA, Hibma M, Mahony TJ, Tu T, Center RJ, Shrestha LB, Hall R, Warner M, Ward V, Anderson DE, Eyre NS, Netzler NE, Peel AJ, Revill P, Beard M, Legione AR, Spencer AJ, Idris A, Forwood J, Sarker S, Purcell DFJ, Bartlett N, Deerain JM, Brew BJ, Asgari S, Farrell H, Khromykh A, Enosi Tuipulotu D, Anderson D, Mese S, Tayyar Y, Edenborough K, Uddin JM, Hussain A, Daymond CJI, Agius J, Johnson KN, Shirmast P, Abedinzadeshahri M, MacDiarmid R, Ashley CL, Laws J, Furfaro LL, Burton TD, Johnson SMR, Telikani Z, Petrone M, Roby JA, Samer C, Suhrbier A, Van Der Kamp A, Cunningham A, Donato C, Mahar J, Black WD, Vasudevan S, Lenchine R, Spann K, Rawle DJ, Rudd P, Neil J, Kingston R, Newsome TP, Kim KW, Mak J, Lowry K, Bryant N, Meers J, Roberts JA, McMillan N, Labzin LI, Slonchak A, Hugo LE, Henzeler B, Newton ND, David CT, Reading PC, Esneau C, Briody T, Nasr N, McNeale D, McSharry B, Fakhri O, Horsburgh BA, Logan G, Howley P, Young P. Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse". mBio 2023:e0081523. [PMID: 37097032 DOI: 10.1128/mbio.00815-23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/26/2023] Open
Affiliation(s)
- Peter Speck
- Flinders University, Bedford Park, South Australia
| | - Jason Mackenzie
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | - Rowena A Bull
- Kirby Institute, University of New South Wales, Sydney, Australia
| | | | | | | | - Lara Herrero
- Griffith University, Southport, Queensland, Australia
| | - Karla Helbig
- La Trobe University, Melbourne, Victoria, Australia
| | - Sarah Londrigan
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | | | - Natalie Prow
- Hull York Medical School, University of York, York, United Kingdom
| | - Grant Hansman
- Griffith University, Southport, Queensland, Australia
| | | | | | | | - David Tscharke
- Australian National University, Canberra, Australian Capital Territory, Australia
| | | | | | - Rhys Parry
- University of Queensland, St. Lucia, Queensland, Australia
| | - Glenn Marsh
- Commonwealth Scientific and Industrial Research Organisation, Geelong, Victoria, Australia
| | - Emma Harding
- University of New South Wales, Sydney, New South Wales, Australia
| | - David A Jacques
- University of New South Wales, Sydney, New South Wales, Australia
| | - Matthew J Gartner
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | - Wen Shi Lee
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | - Julie McAuley
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | - Paola Vaz
- University of Melbourne, Melbourne, Victoria, Australia
| | | | - Michelle D Tate
- Monash University, Melbourne, Victoria, Australia
- Hudson Institute of Medical Research, Clayton, Victoria, Australia
| | - Jane Sinclair
- University of Queensland, St. Lucia, Queensland, Australia
| | - Allison Imrie
- University of Western Australia, Perth, Western Australia, Australia
| | | | - Andrew Harman
- The University of Sydney, New South Wales, Australia
- Westmead Institute for Medical Research, Westmead, New South Wales, Australia
| | | | | | | | | | - Thomas Tu
- The University of Sydney, New South Wales, Australia
- Westmead Institute for Medical Research, Westmead, New South Wales, Australia
| | | | | | - Robyn Hall
- Ausvet Pty Ltd., Canberra, Australian Capital Territory, Australia
- Commonwealth Scientific and Industrial Research Organisation, Black Mountain, Australian Capital Territory, Australia
| | - Morgyn Warner
- University of Adelaide, Adelaide, South Australia, Australia
- SA Pathology, Adelaide, South Australia, Australia
| | | | - Danielle E Anderson
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | | | - Natalie E Netzler
- University of Auckland, Auckland, New Zealand
- Maurice Wilkins Centre of Research Excellence, Auckland, New Zealand
| | | | - Peter Revill
- Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
| | - Michael Beard
- University of Adelaide, Adelaide, South Australia, Australia
| | | | | | - Adi Idris
- Griffith University, Southport, Queensland, Australia
- Queensland University of Technology, Brisbane, Queensland, Australia
| | - Jade Forwood
- Charles Sturt University, Wagga Wagga, New South Wales, Australia
| | - Subir Sarker
- La Trobe University, Melbourne, Victoria, Australia
| | - Damian F J Purcell
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | - Nathan Bartlett
- The University of Newcastle, Newcastle, New South Wales, Australia
| | - Joshua M Deerain
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | - Bruce J Brew
- University of New South Wales, Sydney, New South Wales, Australia
- University of Notre Dame, Sydney, New South Wales, Australia
- St. Vincent's Hospital, Sydney, New South Wales, Australia
| | - Sassan Asgari
- University of Queensland, St. Lucia, Queensland, Australia
| | - Helen Farrell
- University of Queensland, St. Lucia, Queensland, Australia
| | | | | | | | - Sevim Mese
- University of Queensland, St. Lucia, Queensland, Australia
- Istanbul University, Istanbul, Turkey
| | - Yaman Tayyar
- Griffith University, Southport, Queensland, Australia
- Prorenata Biotech, Moledinar, Queensland, Australia
| | | | | | - Abrar Hussain
- Balochistan University of Information Technology, Engineering and Management Sciences, Quetta, Pakistan
| | - Connor J I Daymond
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | | | | | | | | | - Robin MacDiarmid
- The New Zealand Institute for Plant & Food Research Limited, Auckland, New Zealand
| | | | - Jay Laws
- La Trobe University, Melbourne, Victoria, Australia
| | - Lucy L Furfaro
- University of Western Australia, Perth, Western Australia, Australia
| | | | | | | | - Mary Petrone
- The University of Sydney, New South Wales, Australia
| | - Justin A Roby
- Charles Sturt University, Wagga Wagga, New South Wales, Australia
| | - Carolyn Samer
- The University of Sydney, New South Wales, Australia
| | - Andreas Suhrbier
- University of Queensland, St. Lucia, Queensland, Australia
- QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia
| | | | - Anthony Cunningham
- The University of Sydney, New South Wales, Australia
- Westmead Institute for Medical Research, Westmead, New South Wales, Australia
| | - Celeste Donato
- Murdoch Children's Research Institute, Melbourne, Victoria, Australia
| | - Jackie Mahar
- The University of Sydney, New South Wales, Australia
| | - Wesley D Black
- Biotopia Environmental Assessment Pty Ltd., Melbourne, Victoria, Australia
| | | | | | - Kirsten Spann
- Queensland University of Technology, Brisbane, Queensland, Australia
| | - Daniel J Rawle
- QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia
| | - Penny Rudd
- Griffith University, Southport, Queensland, Australia
| | - Jessica Neil
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | | | | | - Ki Wook Kim
- University of New South Wales, Sydney, New South Wales, Australia
| | - Johnson Mak
- Griffith University, Southport, Queensland, Australia
| | - Kym Lowry
- University of Queensland, St. Lucia, Queensland, Australia
| | - Nathan Bryant
- The University of Newcastle, Newcastle, New South Wales, Australia
| | - Joanne Meers
- University of Queensland, St. Lucia, Queensland, Australia
| | - Jason A Roberts
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
- Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
| | | | | | | | - Leon E Hugo
- QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia
| | | | | | | | - Patrick C Reading
- University of Melbourne, Melbourne, Victoria, Australia
- WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, Australia
| | - Camille Esneau
- The University of Newcastle, Newcastle, New South Wales, Australia
| | - Tatiana Briody
- University of Queensland, St. Lucia, Queensland, Australia
| | - Najla Nasr
- The University of Sydney, New South Wales, Australia
- Westmead Institute for Medical Research, Westmead, New South Wales, Australia
| | | | - Brian McSharry
- Charles Sturt University, Wagga Wagga, New South Wales, Australia
| | - Omid Fakhri
- Commonwealth Scientific and Industrial Research Organisation, Black Mountain, Australian Capital Territory, Australia
| | | | - Grant Logan
- Children's Medical Research Institute, Westmead, NSW, Australia
| | - Paul Howley
- Vaxmed Pty Ltd., Berwick, Victoria, Australia
| | - Paul Young
- University of Queensland, St. Lucia, Queensland, Australia
| |
Collapse
|
4
|
Speck P, Mackenzie J, Bull RA, Slobedman B, Drummer H, Fraser J, Herrero L, Helbig K, Londrigan S, Moseley G, Prow N, Hansman G, Edwards R, Ahlenstiel C, Abendroth A, Tscharke D, Hobson-Peters J, Kriiger-Loterio R, Parry R, Marsh G, Harding E, Jacques DA, Gartner MJ, Lee WS, McAuley J, Vaz P, Sainsbury F, Tate MD, Sinclair J, Imrie A, Rawlinson S, Harman A, Carr JM, Monson EA, Hibma M, Mahony TJ, Tu T, Center RJ, Shrestha LB, Hall R, Warner M, Ward V, Anderson DE, Eyre NS, Netzler NE, Peel AJ, Revill P, Beard M, Legione AR, Spencer AJ, Idris A, Forwood J, Sarker S, Purcell DFJ, Bartlett N, Deerain JM, Brew BJ, Asgari S, Farrell H, Khromykh A, Enosi Tuipulotu D, Anderson D, Mese S, Tayyar Y, Edenborough K, Uddin JM, Hussain A, Daymond CJI, Agius J, Johnson KN, Shirmast P, Abedinzadeshahri M, MacDiarmid R, Ashley CL, Laws J, Furfaro LL, Burton TD, Johnson SMR, Telikani Z, Petrone M, Roby JA, Samer C, Suhrbier A, Van Der Kamp A, Cunningham A, Donato C, Mahar J, Black WD, Vasudevan S, Lenchine R, Spann K, Rawle DJ, Rudd P, Neil J, Kingston R, Newsome TP, Kim KW, Mak J, Lowry K, Bryant N, Meers J, Roberts JA, McMillan N, Labzin LI, Slonchak A, Hugo LE, Henzeler B, Newton ND, David CT, Reading PC, Esneau C, Briody T, Nasr N, McNeale D, McSharry B, Fakhri O, Horsburgh BA, Logan G, Howley P, Young P. Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse". mSphere 2023:e0016523. [PMID: 37097028 DOI: 10.1128/msphere.00165-23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/26/2023] Open
Affiliation(s)
- Peter Speck
- Flinders University, Bedford Park, South Australia
| | - Jason Mackenzie
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | - Rowena A Bull
- Kirby Institute, University of New South Wales, Sydney, Australia
| | | | | | | | - Lara Herrero
- Griffith University, Southport, Queensland, Australia
| | - Karla Helbig
- La Trobe University, Melbourne, Victoria, Australia
| | - Sarah Londrigan
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | | | - Natalie Prow
- Hull York Medical School, University of York, York, United Kingdom
| | - Grant Hansman
- Griffith University, Southport, Queensland, Australia
| | | | | | | | - David Tscharke
- Australian National University, Canberra, Australian Capital Territory, Australia
| | | | | | - Rhys Parry
- University of Queensland, St. Lucia, Queensland, Australia
| | - Glenn Marsh
- Commonwealth Scientific and Industrial Research Organisation, Geelong, Victoria, Australia
| | - Emma Harding
- University of New South Wales, Sydney, New South Wales, Australia
| | - David A Jacques
- University of New South Wales, Sydney, New South Wales, Australia
| | - Matthew J Gartner
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | - Wen Shi Lee
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | - Julie McAuley
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | - Paola Vaz
- University of Melbourne, Melbourne, Victoria, Australia
| | | | - Michelle D Tate
- Monash University, Melbourne, Victoria, Australia
- Hudson Institute of Medical Research, Clayton, Victoria, Australia
| | - Jane Sinclair
- University of Queensland, St. Lucia, Queensland, Australia
| | - Allison Imrie
- University of Western Australia, Perth, Western Australia, Australia
| | | | - Andrew Harman
- The University of Sydney, New South Wales, Australia
- Westmead Institute for Medical Research, Westmead, New South Wales, Australia
| | | | | | | | | | - Thomas Tu
- The University of Sydney, New South Wales, Australia
- Westmead Institute for Medical Research, Westmead, New South Wales, Australia
| | | | | | - Robyn Hall
- Ausvet Pty Ltd., Canberra, Australian Capital Territory, Australia
- Commonwealth Scientific and Industrial Research Organisation, Black Mountain, Australian Capital Territory, Australia
| | - Morgyn Warner
- University of Adelaide, Adelaide, South Australia, Australia
- SA Pathology, Adelaide, South Australia, Australia
| | | | - Danielle E Anderson
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | | | - Natalie E Netzler
- University of Auckland, Auckland, New Zealand
- Maurice Wilkins Centre of Research Excellence, Auckland, New Zealand
| | | | - Peter Revill
- Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
| | - Michael Beard
- University of Adelaide, Adelaide, South Australia, Australia
| | | | | | - Adi Idris
- Griffith University, Southport, Queensland, Australia
- Queensland University of Technology, Brisbane, Queensland, Australia
| | - Jade Forwood
- Charles Sturt University, Wagga Wagga, New South Wales, Australia
| | - Subir Sarker
- La Trobe University, Melbourne, Victoria, Australia
| | - Damian F J Purcell
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | - Nathan Bartlett
- The University of Newcastle, Newcastle, New South Wales, Australia
| | - Joshua M Deerain
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | - Bruce J Brew
- University of New South Wales, Sydney, New South Wales, Australia
- University of Notre Dame, Sydney, New South Wales, Australia
- St. Vincent's Hospital, Sydney, New South Wales, Australia
| | - Sassan Asgari
- University of Queensland, St. Lucia, Queensland, Australia
| | - Helen Farrell
- University of Queensland, St. Lucia, Queensland, Australia
| | | | | | | | - Sevim Mese
- University of Queensland, St. Lucia, Queensland, Australia
- Istanbul University, Istanbul, Turkey
| | - Yaman Tayyar
- Griffith University, Southport, Queensland, Australia
- Prorenata Biotech, Moledinar, Queensland, Australia
| | | | | | - Abrar Hussain
- Balochistan University of Information Technology, Engineering and Management Sciences, Quetta, Pakistan
| | - Connor J I Daymond
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | | | | | | | | | - Robin MacDiarmid
- The New Zealand Institute for Plant & Food Research Limited, Auckland, New Zealand
| | | | - Jay Laws
- La Trobe University, Melbourne, Victoria, Australia
| | - Lucy L Furfaro
- University of Western Australia, Perth, Western Australia, Australia
| | | | | | | | - Mary Petrone
- The University of Sydney, New South Wales, Australia
| | - Justin A Roby
- Charles Sturt University, Wagga Wagga, New South Wales, Australia
| | - Carolyn Samer
- The University of Sydney, New South Wales, Australia
| | - Andreas Suhrbier
- University of Queensland, St. Lucia, Queensland, Australia
- QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia
| | | | - Anthony Cunningham
- The University of Sydney, New South Wales, Australia
- Westmead Institute for Medical Research, Westmead, New South Wales, Australia
| | - Celeste Donato
- Murdoch Children's Research Institute, Melbourne, Victoria, Australia
| | - Jackie Mahar
- The University of Sydney, New South Wales, Australia
| | - Wesley D Black
- Biotopia Environmental Assessment Pty Ltd., Melbourne, Victoria, Australia
| | | | | | - Kirsten Spann
- Queensland University of Technology, Brisbane, Queensland, Australia
| | - Daniel J Rawle
- QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia
| | - Penny Rudd
- Griffith University, Southport, Queensland, Australia
| | - Jessica Neil
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | | | | | - Ki Wook Kim
- University of New South Wales, Sydney, New South Wales, Australia
| | - Johnson Mak
- Griffith University, Southport, Queensland, Australia
| | - Kym Lowry
- University of Queensland, St. Lucia, Queensland, Australia
| | - Nathan Bryant
- The University of Newcastle, Newcastle, New South Wales, Australia
| | - Joanne Meers
- University of Queensland, St. Lucia, Queensland, Australia
| | - Jason A Roberts
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
- Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
| | | | | | | | - Leon E Hugo
- QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia
| | | | | | | | - Patrick C Reading
- University of Melbourne, Melbourne, Victoria, Australia
- WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, Australia
| | - Camille Esneau
- The University of Newcastle, Newcastle, New South Wales, Australia
| | - Tatiana Briody
- University of Queensland, St. Lucia, Queensland, Australia
| | - Najla Nasr
- The University of Sydney, New South Wales, Australia
- Westmead Institute for Medical Research, Westmead, New South Wales, Australia
| | | | - Brian McSharry
- Charles Sturt University, Wagga Wagga, New South Wales, Australia
| | - Omid Fakhri
- Commonwealth Scientific and Industrial Research Organisation, Black Mountain, Australian Capital Territory, Australia
| | | | - Grant Logan
- Children's Medical Research Institute, Westmead, NSW, Australia
| | - Paul Howley
- Vaxmed Pty Ltd., Berwick, Victoria, Australia
| | - Paul Young
- University of Queensland, St. Lucia, Queensland, Australia
| |
Collapse
|
5
|
Speck P, Mackenzie J, Bull RA, Slobedman B, Drummer H, Fraser J, Herrero L, Helbig K, Londrigan S, Moseley G, Prow N, Hansman G, Edwards R, Ahlenstiel C, Abendroth A, Tscharke D, Hobson-Peters J, Kriiger-Loterio R, Parry R, Marsh G, Harding E, Jacques DA, Gartner MJ, Lee WS, McAuley J, Vaz P, Sainsbury F, Tate MD, Sinclair J, Imrie A, Rawlinson S, Harman A, Carr JM, Monson EA, Hibma M, Mahony TJ, Tu T, Center RJ, Shrestha LB, Hall R, Warner M, Ward V, Anderson DE, Eyre NS, Netzler NE, Peel AJ, Revill P, Beard M, Legione AR, Spencer AJ, Idris A, Forwood J, Sarker S, Purcell DFJ, Bartlett N, Deerain JM, Brew BJ, Asgari S, Farrell H, Khromykh A, Enosi Tuipulotu D, Anderson D, Mese S, Tayyar Y, Edenborough K, Uddin JM, Hussain A, Daymond CJI, Agius J, Johnson KN, Shirmast P, Abedinzadeshahri M, MacDiarmid R, Ashley CL, Laws J, Furfaro LL, Burton TD, Johnson SMR, Telikani Z, Petrone M, Roby JA, Samer C, Suhrbier A, Van Der Kamp A, Cunningham A, Donato C, Mahar J, Black WD, Vasudevan S, Lenchine R, Spann K, Rawle DJ, Rudd P, Neil J, Kingston R, Newsome TP, Kim KW, Mak J, Lowry K, Bryant N, Meers J, Roberts JA, McMillan N, Labzin LI, Slonchak A, Hugo LE, Henzeler B, Newton ND, David CT, Reading PC, Esneau C, Briody T, Nasr N, McNeale D, McSharry B, Fakhri O, Horsburgh BA, Logan G, Howley P, Young P. Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse". J Virol 2023; 97:e0045123. [PMID: 37097023 DOI: 10.1128/jvi.00451-23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/26/2023] Open
Affiliation(s)
- Peter Speck
- Flinders University, Bedford Park, South Australia
| | - Jason Mackenzie
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | - Rowena A Bull
- Kirby Institute, University of New South Wales, Sydney, Australia
| | | | | | | | - Lara Herrero
- Griffith University, Southport, Queensland, Australia
| | - Karla Helbig
- La Trobe University, Melbourne, Victoria, Australia
| | - Sarah Londrigan
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | | | - Natalie Prow
- Hull York Medical School, University of York, York, United Kingdom
| | - Grant Hansman
- Griffith University, Southport, Queensland, Australia
| | | | | | | | - David Tscharke
- Australian National University, Canberra, Australian Capital Territory, Australia
| | | | | | - Rhys Parry
- University of Queensland, St. Lucia, Queensland, Australia
| | - Glenn Marsh
- Commonwealth Scientific and Industrial Research Organisation, Geelong, Victoria, Australia
| | - Emma Harding
- University of New South Wales, Sydney, New South Wales, Australia
| | - David A Jacques
- University of New South Wales, Sydney, New South Wales, Australia
| | - Matthew J Gartner
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | - Wen Shi Lee
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | - Julie McAuley
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | - Paola Vaz
- University of Melbourne, Melbourne, Victoria, Australia
| | | | - Michelle D Tate
- Monash University, Melbourne, Victoria, Australia
- Hudson Institute of Medical Research, Clayton, Victoria, Australia
| | - Jane Sinclair
- University of Queensland, St. Lucia, Queensland, Australia
| | - Allison Imrie
- University of Western Australia, Perth, Western Australia, Australia
| | | | - Andrew Harman
- The University of Sydney, New South Wales, Australia
- Westmead Institute for Medical Research, Westmead, New South Wales, Australia
| | | | | | | | | | - Thomas Tu
- The University of Sydney, New South Wales, Australia
- Westmead Institute for Medical Research, Westmead, New South Wales, Australia
| | | | | | - Robyn Hall
- Ausvet Pty Ltd., Canberra, Australian Capital Territory, Australia
- Commonwealth Scientific and Industrial Research Organisation, Black Mountain, Australian Capital Territory, Australia
| | - Morgyn Warner
- University of Adelaide, Adelaide, South Australia, Australia
- SA Pathology, Adelaide, South Australia, Australia
| | | | - Danielle E Anderson
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | | | - Natalie E Netzler
- University of Auckland, Auckland, New Zealand
- Maurice Wilkins Centre of Research Excellence, Auckland, New Zealand
| | | | - Peter Revill
- Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
| | - Michael Beard
- University of Adelaide, Adelaide, South Australia, Australia
| | | | | | - Adi Idris
- Griffith University, Southport, Queensland, Australia
- Queensland University of Technology, Brisbane, Queensland, Australia
| | - Jade Forwood
- Charles Sturt University, Wagga Wagga, New South Wales, Australia
| | - Subir Sarker
- La Trobe University, Melbourne, Victoria, Australia
| | - Damian F J Purcell
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | - Nathan Bartlett
- The University of Newcastle, Newcastle, New South Wales, Australia
| | - Joshua M Deerain
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | - Bruce J Brew
- University of New South Wales, Sydney, New South Wales, Australia
- University of Notre Dame, Sydney, New South Wales, Australia
- St. Vincent's Hospital, Sydney, New South Wales, Australia
| | - Sassan Asgari
- University of Queensland, St. Lucia, Queensland, Australia
| | - Helen Farrell
- University of Queensland, St. Lucia, Queensland, Australia
| | | | | | | | - Sevim Mese
- University of Queensland, St. Lucia, Queensland, Australia
- Istanbul University, Istanbul, Turkey
| | - Yaman Tayyar
- Griffith University, Southport, Queensland, Australia
- Prorenata Biotech, Moledinar, Queensland, Australia
| | | | | | - Abrar Hussain
- Balochistan University of Information Technology, Engineering and Management Sciences, Quetta, Pakistan
| | - Connor J I Daymond
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | | | | | | | | | - Robin MacDiarmid
- The New Zealand Institute for Plant & Food Research Limited, Auckland, New Zealand
| | | | - Jay Laws
- La Trobe University, Melbourne, Victoria, Australia
| | - Lucy L Furfaro
- University of Western Australia, Perth, Western Australia, Australia
| | | | | | | | - Mary Petrone
- The University of Sydney, New South Wales, Australia
| | - Justin A Roby
- Charles Sturt University, Wagga Wagga, New South Wales, Australia
| | - Carolyn Samer
- The University of Sydney, New South Wales, Australia
| | - Andreas Suhrbier
- University of Queensland, St. Lucia, Queensland, Australia
- QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia
| | | | - Anthony Cunningham
- The University of Sydney, New South Wales, Australia
- Westmead Institute for Medical Research, Westmead, New South Wales, Australia
| | - Celeste Donato
- Murdoch Children's Research Institute, Melbourne, Victoria, Australia
| | - Jackie Mahar
- The University of Sydney, New South Wales, Australia
| | - Wesley D Black
- Biotopia Environmental Assessment Pty Ltd., Melbourne, Victoria, Australia
| | | | | | - Kirsten Spann
- Queensland University of Technology, Brisbane, Queensland, Australia
| | - Daniel J Rawle
- QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia
| | - Penny Rudd
- Griffith University, Southport, Queensland, Australia
| | - Jessica Neil
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
| | | | | | - Ki Wook Kim
- University of New South Wales, Sydney, New South Wales, Australia
| | - Johnson Mak
- Griffith University, Southport, Queensland, Australia
| | - Kym Lowry
- University of Queensland, St. Lucia, Queensland, Australia
| | - Nathan Bryant
- The University of Newcastle, Newcastle, New South Wales, Australia
| | - Joanne Meers
- University of Queensland, St. Lucia, Queensland, Australia
| | - Jason A Roberts
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia
- Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
| | | | | | | | - Leon E Hugo
- QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia
| | | | | | | | - Patrick C Reading
- University of Melbourne, Melbourne, Victoria, Australia
- WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, Australia
| | - Camille Esneau
- The University of Newcastle, Newcastle, New South Wales, Australia
| | - Tatiana Briody
- University of Queensland, St. Lucia, Queensland, Australia
| | - Najla Nasr
- The University of Sydney, New South Wales, Australia
- Westmead Institute for Medical Research, Westmead, New South Wales, Australia
| | | | - Brian McSharry
- Charles Sturt University, Wagga Wagga, New South Wales, Australia
| | - Omid Fakhri
- Commonwealth Scientific and Industrial Research Organisation, Black Mountain, Australian Capital Territory, Australia
| | | | - Grant Logan
- Children's Medical Research Institute, Westmead, NSW, Australia
| | - Paul Howley
- Vaxmed Pty Ltd., Berwick, Victoria, Australia
| | - Paul Young
- University of Queensland, St. Lucia, Queensland, Australia
| |
Collapse
|
6
|
Logue M, Haylock C, Scarborough C, Mackenzie J. "If people are hesitant at all, you just want a really big front door": a rapid qualitative interview study on the Luton COVID-19 vaccination outreach clinics. BMC Public Health 2023; 23:440. [PMID: 36882718 PMCID: PMC9990003 DOI: 10.1186/s12889-023-15016-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2022] [Accepted: 01/10/2023] [Indexed: 03/09/2023] Open
Abstract
BACKGROUND There is a lack of evidence on the usefulness, practicality, and acceptance of vaccination outreach clinics in the community especially during pandemics. In this qualitative study, we explored the experiences, motivations and perceptions of service users, health professionals, strategic staff, volunteers, and community workers involved in the COVID-19 vaccination outreach clinics in Luton. METHODS Semi structured face to face, telephone, online interviews, and focus groups were conducted with 31 participants including health professionals, strategic staff, volunteers, community workers and service users. The Framework Method was used to analyse the data and generate themes. RESULTS Service users expressed positivity towards the convenience and familiarity of the location of the vaccination outreach clinics and the flexibility of receiving the vaccination in a local setting. Participants involved in the planning and delivery of the service commented on the worthwhile and rewarding experience but suggested more attention should be given to preparation time, service user recruitment, the working environment, and staff welfare. CONCLUSIONS The COVID-19 mobile vaccination outreach clinics in Luton tested and developed a different model of service delivery and demonstrated a collaborative way of working: "taking the health service to the patient, not the patient to the health service". Planning and local community engagement were seen as key to successful delivery of a mobile healthcare service.
Collapse
Affiliation(s)
- M Logue
- Hertfordshire County Council, Public Health Evidence and Intelligence, Public Health, County Hall, Pegs Lane, Hertford, SG13 8DQ, UK. .,University of Southampton, Primary Care, Medical Education and Population Science, Aldermoor Health Centre, Southampton, SO16 5ST, UK.
| | - C Haylock
- Hertfordshire County Council, Public Health Evidence and Intelligence, Public Health, County Hall, Pegs Lane, Hertford, SG13 8DQ, UK
| | - C Scarborough
- Luton Borough Council Public Health, Third floor, Arndale House, The Mall, Luton, LU1 2LJ, UK
| | - J Mackenzie
- Hertfordshire County Council, Public Health Evidence and Intelligence, Public Health, County Hall, Pegs Lane, Hertford, SG13 8DQ, UK
| |
Collapse
|
7
|
Challapalli A, Watkins S, Cogill G, Stewart G, Ellis S, Sykes A, Nobes J, Yip K, Barthakur U, Board R, Gadve A, O'Toole L, Kent C, Mackenzie J, Papa S, Fusi A, Fife K. Cemiplimab in advanced cutaneous squamous cell carcinoma: UK experience from the Named Patient Scheme. J Eur Acad Dermatol Venereol 2022; 36:e590-e592. [PMID: 35298050 DOI: 10.1111/jdv.18082] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2021] [Revised: 02/09/2022] [Accepted: 03/02/2022] [Indexed: 11/28/2022]
Affiliation(s)
- A Challapalli
- University Hospitals Bristol & Weston NHS Foundation Trust
| | - S Watkins
- University Hospitals Birmingham NHS Foundation Trust
| | - G Cogill
- University Hospitals Plymouth NHS Trust
| | | | - S Ellis
- Portsmouth Hospitals NHS Trust
| | - A Sykes
- The Christie NHS Foundation Trust
| | - J Nobes
- Norfolk and Norwich University Hospitals NHS Foundation Trust
| | - K Yip
- East Suffolk and North Essex NHS Foundation Trust
| | | | - R Board
- Lancashire Teaching Hospitals NHS Foundation Trust
| | - A Gadve
- NHS Greater Glasgow and Clyde
| | - L O'Toole
- Hull University Teaching Hospitals NHS Trust
| | - C Kent
- University Hospitals of Leicester NHS Trust
| | | | - S Papa
- School of Cancer and Pharmaceutical Studies, King's College London
| | - A Fusi
- St George's University Hospitals NHS Foundation Trust
| | - K Fife
- Cambridge University Hospitals NHS Foundation Trust, UK
| |
Collapse
|
8
|
Wu H, Mackenzie J. Dual-Gendered Leadership: Gender-Inclusive Scientific-Political Public Health Communication Supporting Government COVID-19 Responses in Atlantic Canada. Healthcare (Basel) 2021; 9:1345. [PMID: 34683024 PMCID: PMC8544510 DOI: 10.3390/healthcare9101345] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2021] [Revised: 10/05/2021] [Accepted: 10/07/2021] [Indexed: 02/01/2023] Open
Abstract
This research aims to identify the influence of woman leadership on improving the traditional man-dominated scientific-political communication towards positive COVID-19-driven public health interventions. Across Canada, dual-gendered leadership (women chief medical officers and men prime minister/premiers) at both federal and provincial levels illustrated a positive approach to "flatten the curve" during the first and second waves of COVID-19. With the four provinces of New Brunswick, Newfoundland and Labrador, Nova Scotia, and Prince Edward Island, Atlantic Canada formed the "Atlantic Bubble", which has become a great example domestically and internationally of successfully mitigating the pandemic while maintaining societal operation. Three provinces have benefitted from this complementary dual-gendered leadership. This case study utilized a scoping media coverage review approach, quantitatively examining how gender-inclusive scientific-political cooperation supported effective provincial responses in Atlantic Canada during the first two waves of COVID-19. This case study discovers that (1) at the provincial government level, woman leadership of mitigation, advocating, and coordination encouraged provincial authorities to adapt science-based interventions and deliver consistent and supportive public health information to the general public; and (2) at the community level, this dual-gendered leadership advanced community cohesion toward managing the community-based spread of COVID-19. Future studies may apply a longitudinal, retrospective approach with Canada-wide or cross-national comparison to further evaluate the strengths and weaknesses of dual-gendered leadership.
Collapse
Affiliation(s)
- Haorui Wu
- School of Social Work, Dalhousie University, Halifax, NS B3H 4R2, Canada;
- Natural Hazards Center, University of Colorado Boulder, Boulder, CO 80309, USA
| | - Jason Mackenzie
- School of Social Work, Dalhousie University, Halifax, NS B3H 4R2, Canada;
| |
Collapse
|
9
|
Slonchak A, Clarke B, Mackenzie J, Amarilla AA, Setoh YX, Khromykh AA. West Nile virus infection and interferon alpha treatment alter the spectrum and the levels of coding and noncoding host RNAs secreted in extracellular vesicles. BMC Genomics 2019; 20:474. [PMID: 31182021 PMCID: PMC6558756 DOI: 10.1186/s12864-019-5835-6] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2018] [Accepted: 05/23/2019] [Indexed: 12/13/2022] Open
Abstract
BACKGROUND Extracellular vesicles (EVs) are small membrane vesicles secreted by the cells that mediate intercellular transfer of molecules and contribute to transduction of various signals. Viral infection and action of pro-inflammatory cytokines has been shown to alter molecular composition of EV content. Transfer of antiviral proteins by EVs is thought to contribute to the development of inflammation and antiviral state. Altered incorporation of selected host RNAs into EVs in response to infection has also been demonstrated for several viruses, but not for WNV. Considering the medical significance of flaviviruses and the importance of deeper knowledge about the mechanisms of flavivirus-host interactions we assessed the ability of West Nile virus (WNV) and type I interferon (IFN), the main cytokine regulating antiviral response to WNV, to alter the composition of EV RNA cargo. RESULTS We employed next generation sequencing to perform transcriptome-wide profiling of RNA cargo in EVs produced by cells infected with WNV or exposed to IFN-alpha. RNA profile of EVs secreted by uninfected cells was also determined and used as a reference. We found that WNV infection significantly changed the levels of certain host microRNAs (miRNAs), small noncoding RNAs (sncRNAs) and mRNAs incorporated into EVs. Treatment with IFN-alpha also altered miRNA and mRNA profiles in EV but had less profound effect on sncRNAs. Functional classification of RNAs differentially incorporated into EVs upon infection and in response to IFN-alpha treatment demonstrated association of enriched in EVs mRNAs and miRNAs with viral processes and pro-inflammatory pathways. Further analysis revealed that WNV infection and IFN-alpha treatment changed the levels of common and unique mRNAs and miRNAs in EVs and that IFN-dependent and IFN-independent processes are involved in regulation of RNA sorting into EVs during infection. CONCLUSIONS WNV infection and IFN-alpha treatment alter the spectrum and the levels of mRNAs, miRNAs and sncRNAs in EVs. Differentially incorporated mRNAs and miRNAs in EVs produced in response to WNV infection and to IFN-alpha treatment are associated with viral processes and host response to infection. WNV infection affects composition of RNA cargo in EVs via IFN-dependent and IFN-independent mechanisms.
Collapse
Affiliation(s)
- Andrii Slonchak
- The Australian Infectious Diseases Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, MBS building 76, Cooper Rd, St Lucia, QLD, 4072, Australia
| | - Brian Clarke
- The Australian Infectious Diseases Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, MBS building 76, Cooper Rd, St Lucia, QLD, 4072, Australia
- The Pirbright Institute, Ash Rd, Pirbright, Surrey, GU24 GNF, UK
| | - Jason Mackenzie
- The Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, The University of Melbourne, 792 Elizabeth Street, Melbourne, VIC, 3000, Australia
| | - Alberto Anastacio Amarilla
- The Australian Infectious Diseases Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, MBS building 76, Cooper Rd, St Lucia, QLD, 4072, Australia
| | - Yin Xiang Setoh
- The Australian Infectious Diseases Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, MBS building 76, Cooper Rd, St Lucia, QLD, 4072, Australia
| | - Alexander A Khromykh
- The Australian Infectious Diseases Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, MBS building 76, Cooper Rd, St Lucia, QLD, 4072, Australia.
| |
Collapse
|
10
|
Di Loreto C, Dutschke J, Forrest M, Van Den Berg A, Chardonnet J, Mérienne F, Mackenzie J, Sandoz B. Head dynamics during emergency braking events. Comput Methods Biomech Biomed Engin 2019. [DOI: 10.1080/10255842.2020.1714249] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Affiliation(s)
- C. Di Loreto
- Arts et Metiers, IBHGC, Paris, France
- Arts et Metiers, LISPEN, Chalon-Sur-Saône, France
| | - J. Dutschke
- University of Adelaide, CASR, Adelaide, Australia
| | - M. Forrest
- University of Adelaide, CASR, Adelaide, Australia
| | | | | | - F. Mérienne
- Arts et Metiers, LISPEN, Chalon-Sur-Saône, France
| | - J. Mackenzie
- University of Adelaide, CASR, Adelaide, Australia
| | - B. Sandoz
- Arts et Metiers, IBHGC, Paris, France
| |
Collapse
|
11
|
Mackenzie J, Fairbairn I, North F, Quirie C. Medical thoracoscopy in a DGH: 1-year activity. Lung Cancer 2019. [DOI: 10.1016/s0169-5002(19)30114-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
12
|
Bartlett S, Mackenzie J, Fairbairn I, Stevenson M. Indwelling pleural catheters in Fife: indications and outcomes. Lung Cancer 2019. [DOI: 10.1016/s0169-5002(19)30118-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
13
|
El Tawil S, Chohan G, Mackenzie J, Rowe A, Weller B, Will RG, Knight R. Isolated language impairment as the primary presentation of sporadic Creutzfeldt Jakob Disease. Acta Neurol Scand 2017; 135:316-323. [PMID: 27072062 DOI: 10.1111/ane.12600] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/24/2016] [Indexed: 11/30/2022]
Abstract
OBJECTIVES Sporadic Creutzfeldt Jakob Disease (sCJD) is a neurodegenerative disorder that typically presents as a rapidly progressive encephalopathy associated with various neurological features, culminating in akinetic mutism and death. Atypical cases, presenting with an isolated focal may cause diagnostic confusion. We described a series of patients with sCJD presenting with isolated language impairment. MATERIALS & METHODS We report a patient with sCJD referred to the NCJDRSU, who presented with isolated language impairment and subsequently identified all cases of sporadic CJD on the NCJDRSU database (covering the years 1990-2012) with an isolated language impairment presentation. RESULTS Nineteen patients (11 females) with sCJD (1.19% of all patients) had an isolated language disorder of at least 2 weeks duration as the first neurological symptom pattern. Mean age at onset was 68.28 years. No specific pattern of language affection was seen in these patients. Further progression usually affected more than one neurological domain, with all patients eventually developing cognitive decline and myoclonic jerks. The median duration of illness was 4 months. CSF 14.3.3 was positive and S100b level was elevated in all patients in whom it was performed. EEG and MRI showed typical features of sCJD in six patients each. Most patients showed MM genotype of PRNP codon 129. CONCLUSION This study highlights the fact that isolated aphasia can be the first neurological symptom approximately in 1% of patients with sCJD. The diagnosis is usually made with appearance of other clinical features and investigation results, but in a small minority, these may not be apparent for relatively long periods.
Collapse
Affiliation(s)
- S. El Tawil
- National CJD Research & Surveillance Unit; University of Edinburgh; Edinburgh UK
| | - G. Chohan
- National CJD Research & Surveillance Unit; University of Edinburgh; Edinburgh UK
| | - J. Mackenzie
- National CJD Research & Surveillance Unit; University of Edinburgh; Edinburgh UK
| | - A. Rowe
- Department of Clinical Neurosciences; Western General Hospital; Edinburgh UK
| | - B. Weller
- Department of Clinical Neurosciences; Western General Hospital; Edinburgh UK
| | - R. G. Will
- National CJD Research & Surveillance Unit; University of Edinburgh; Edinburgh UK
| | - R. Knight
- National CJD Research & Surveillance Unit; University of Edinburgh; Edinburgh UK
| |
Collapse
|
14
|
Taylor L, Aujayeb A, Calder M, Nicholson S, Mackenzie J, Dickson M. 146: Treatment of loculated malignant effusions. Lung Cancer 2017. [DOI: 10.1016/s0169-5002(17)30196-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
15
|
Mackenzie J, Graham G, Olivotto I. Peer Review of Radiotherapy Planning: Quantifying Outcomes and a Proposal for Prospective Data Collection. Clin Oncol (R Coll Radiol) 2016; 28:e192-e198. [DOI: 10.1016/j.clon.2016.08.012] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2016] [Revised: 06/20/2016] [Accepted: 07/20/2016] [Indexed: 11/28/2022]
|
16
|
Mackenzie J, Conroy K, De P. 92 Final diagnosis for patients referred to pleural clinic. Lung Cancer 2016. [DOI: 10.1016/s0169-5002(16)30109-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
17
|
Simmons CP, McPherson K, Van Vinh Chau N, Hoai Tam DT, Young P, Mackenzie J, Wills B. Recent advances in dengue pathogenesis and clinical management. Vaccine 2015; 33:7061-8. [PMID: 26458808 DOI: 10.1016/j.vaccine.2015.09.103] [Citation(s) in RCA: 49] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2015] [Revised: 09/01/2015] [Accepted: 09/03/2015] [Indexed: 12/31/2022]
Abstract
This review describes and commentates on recent advances in the understanding of dengue pathogenesis and immunity, plus clinical research on vaccines and therapeutics. We expand specifically on the role of the dermis in dengue virus infection, the contribution of cellular and humoral immune responses to pathogenesis and immunity, NS1 and mechanisms of virus immune evasion. Additionally we review a series of therapeutic intervention trials for dengue, as well as recent clinical research aimed at improving clinical diagnosis, risk prediction and disease classification.
Collapse
Affiliation(s)
- Cameron P Simmons
- Oxford University Clinical Research Unit, Hospital for Tropical Diseases, 764 Vo Van Kiet street, District 5, Ho Chi Minh City, Viet Nam; Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria 3010, Australia.
| | - Kirsty McPherson
- Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria 3010, Australia
| | - Nguyen Van Vinh Chau
- Hospital for Tropical Diseases, 764 Vo Van Kiet, District 5, Ho Chi Minh City, Viet Nam
| | - D T Hoai Tam
- University of Medicine and Pharmacy, 217 Hong Bang, District 5, Ho Chi Minh City, Viet Nam
| | - Paul Young
- School of Chemistry and Molecular Biosciences, University of Queensland, Australia
| | - Jason Mackenzie
- Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria 3010, Australia
| | - Bridget Wills
- Oxford University Clinical Research Unit, Hospital for Tropical Diseases, 764 Vo Van Kiet street, District 5, Ho Chi Minh City, Viet Nam; Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
| |
Collapse
|
18
|
Mackenzie J, Schinkel C, Graham D, Bosch J, Banerjee R. 633 Comparing VMAT and IMRT for head and neck cancer throughout treatment: Which technique provides better dosimetry in the context of weight loss and tumor shrinkage? Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)30369-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
19
|
Lew T, Creamer D, Mackenzie J, Walsh S. Post-traumatic stress disorder following drug reaction with eosinophilia and systemic symptoms. Br J Dermatol 2015; 172:836-7. [DOI: 10.1111/bjd.13375] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Affiliation(s)
- T.T. Lew
- Dermatology Department; King's College Hospital NHS Foundation Trust; London SE5 9RS U.K
| | - D. Creamer
- Dermatology Department; King's College Hospital NHS Foundation Trust; London SE5 9RS U.K
| | - J. Mackenzie
- Dermatology Department; King's College Hospital NHS Foundation Trust; London SE5 9RS U.K
| | - S.A. Walsh
- Dermatology Department; King's College Hospital NHS Foundation Trust; London SE5 9RS U.K
| |
Collapse
|
20
|
de Bruin E, Loeber JG, Meijer A, Castillo GM, Cepeda MLG, Torres-Sepúlveda MR, Borrajo GJC, Caggana M, Giguere Y, Meyer M, Fukushi M, Devi ARR, Khneisser I, Vilarinho L, von Döbeln U, Torresani T, Mackenzie J, Zutt I, Schipper M, Elvers LH, Koopmans MPG. Evolution of an influenza pandemic in 13 countries from 5 continents monitored by protein microarray from neonatal screening bloodspots. J Clin Virol 2014; 61:74-80. [PMID: 25017954 DOI: 10.1016/j.jcv.2014.06.020] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2014] [Revised: 06/17/2014] [Accepted: 06/20/2014] [Indexed: 01/15/2023]
Abstract
BACKGROUND Because of lack of worldwide standardization of influenza virus surveillance, comparison between countries of impact of a pandemic is challenging. For that, other approaches to allow internationally comparative serosurveys are welcome. OBJECTIVES Here we explore the use of neonatal screening dried blood spots to monitor the trends of the 2009 influenza A (H1N1) pdm virus by the use of a protein microarray. STUDY DESIGN We contacted colleagues from neonatal screening laboratories and asked for their willingness to participate in a study by testing anonymized neonatal screening bloodspots collected during the course of the pandemic. In total, 7749 dried blood spots from 13 countries in 5 continents where analyzed by using a protein microarray containing HA1 recombinant proteins derived from pandemic influenza A (H1N1) 2009 as well as seasonal influenza viruses. RESULTS Results confirm the early start of the pandemic with extensive circulation in the US and Canada, when circulation of the new virus was limited in other parts of the world. The data collected from sites in Mexico suggested limited circulation of the virus during the early pandemic phase in this country. In contrast and to our surprise, an increase in seroprevalence early in 2009 was noted in the dataset from Argentina, suggestive of much more widespread circulation of the novel virus in this country than in Mexico. CONCLUSIONS We conclude that this uniform serological testing of samples from a highly standardized screening system offers an interesting opportunity for monitoring population level attack rates of widespread diseases outbreaks and pandemics.
Collapse
Affiliation(s)
- E de Bruin
- Laboratory for Infectious Diseases and Perinatal Screening, Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
| | - J G Loeber
- Laboratory for Infectious Diseases and Perinatal Screening, Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
| | - A Meijer
- Laboratory for Infectious Diseases and Perinatal Screening, Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
| | - G Martinez Castillo
- Unidad de Genetica, Hospital Espanol, Centro de Estudios Neonatales y Geneticos, Mexico State, Mexico
| | | | | | - G J C Borrajo
- Fundación Bioquímica Argentina, Programa de Detección de Errores Congénitos, La Plata, Argentina
| | - M Caggana
- New York State Department of Health, Biggs Laboratory, Albany, USA
| | - Y Giguere
- Programme Québécois de Dépistage Néonatal Sanguin, CHU de Québec, Québec, Canada
| | - M Meyer
- North West University, Potchefstroom Campus, Potchefstroom, South Africa
| | - M Fukushi
- Sapporo City Institute of Public Health, Sapporo, Japan
| | | | - I Khneisser
- Neonatal Screening Laboratory, Medical Genetic Unit, Saint Joseph University, Beirut, Lebanon
| | - L Vilarinho
- Neonatal Screening Unit, Genetics Department, National Institute of Health Dr Ricardo Jorge, Porto, Portugal
| | - U von Döbeln
- Karolinska University Hospital Huddinge, Centre for Inherited Metabolic Disease, Stockholm, Sweden
| | - T Torresani
- Universitäts Kinderklinik, Zürich, Switzerland
| | - J Mackenzie
- Yorkhill Hospital, Scottish Newborn Screening Laboratory, Glasgow, United Kingdom
| | - I Zutt
- Laboratory for Infectious Diseases and Perinatal Screening, Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
| | - M Schipper
- Laboratory for Infectious Diseases and Perinatal Screening, Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
| | - L H Elvers
- Laboratory for Infectious Diseases and Perinatal Screening, Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
| | - M P G Koopmans
- Laboratory for Infectious Diseases and Perinatal Screening, Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; Department of Virology, Erasmus Medical Center, Rotterdam, The Netherlands
| |
Collapse
|
21
|
Hoenen A, Gillespie L, Morgan G, van der Heide P, Khromykh A, Mackenzie J. The West Nile virus assembly process evades the conserved antiviral mechanism of the interferon-induced MxA protein. Virology 2014; 448:104-16. [DOI: 10.1016/j.virol.2013.10.005] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2013] [Revised: 06/28/2013] [Accepted: 10/03/2013] [Indexed: 02/04/2023]
|
22
|
|
23
|
|
24
|
Barnes RA, Edghill N, Mackenzie J, Holters G, Ross GP, Jalaludin BB, Flack JR. Predictors of large and small for gestational age birthweight in offspring of women with gestational diabetes mellitus. Diabet Med 2013; 30:1040-6. [PMID: 23551273 DOI: 10.1111/dme.12207] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/12/2012] [Revised: 12/20/2012] [Accepted: 03/22/2013] [Indexed: 12/17/2022]
Abstract
AIM To identify predictors of large and small for gestational age in women with gestational diabetes mellitus. METHODS A retrospective audit of clinical data analysed for singleton births in women diagnosed with gestational diabetes by Australasian Diabetes in Pregnancy Society guidelines from 1994 to 2009. Exclusions were: incomplete data, delivered at < 36 weeks gestation and/or last recorded weight > 4 weeks pre-delivery. We assessed: pre-pregnancy BMI, ethnicity, total maternal weight gain, weight gain before and after treatment initiation for gestational diabetes, HbA(1c) at gestational diabetes presentation and treatment modality (diet or insulin) and smoking. Birthweight was assessed using customized percentile charts (large for gestational age > 90th; small for gestational age < 10th percentile). Multiple regression analyses were undertaken; statistical significance was p < 0.05. RESULTS There were 1695 women first seen at (mean ± sd) 28.1 ± 5.3 weeks gestation (range 6-39). Ethnic mix was South-East Asian 36.7%, Middle Eastern 27.6%, European 22.4%, Indian/Pakistani 8.6%, Samoan 1.9%, African 1.5% and Maori 1.1%. Therapy was diet 69.1% and insulin 30.9%. Mean total weight gain was 12.3 ± 6.1 kg, the majority (10.6 ± 6.0 kg), gained before dietary intervention. There were 7.9% small for gestational age and 15.2% large for gestational age births. Significant independent large for gestational age predictors were: weight gain before intervention, pre-pregnancy BMI, weight gain after intervention and treatment type, but not HbA1c or smoking. Significant small for gestational age predictors were: weight gain before intervention, weight gain after intervention, but not pre-pregnancy BMI, HbA(1c) or smoking. CONCLUSION Conventional treatment for gestational diabetes mellitus concentrates on management of blood glucose levels. The trends identified here emphasize the need to also address pregnancy weight gain stratified by pre-pregnancy BMI.
Collapse
Affiliation(s)
- R A Barnes
- Department of Diabetes and Endocrinology, Bankstown-Lidcombe Hospital, NSW, Australia.
| | | | | | | | | | | | | |
Collapse
|
25
|
Szvetko AL, Jones A, Mackenzie J, Tajouri L, Csurhes PA, Greer JM, Pender MP, Griffiths LR. Investigation of the [−/A]8and C1236T genetic variations within the human toll-like receptor 3 gene for association with multiple sclerosis. Neurol Res 2013; 32:438-41. [DOI: 10.1179/174313209x405155] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
26
|
Varndell W, Mackenzie J, Sands MB. CPR: STAT! OR STOP! THE END-OF-LIFE CARE ELECTRONIC RECORD (ELCER). BMJ Support Palliat Care 2013. [DOI: 10.1136/bmjspcare-2013-000491.20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
27
|
Shaw MR, Klausmeyer K, Cameron DR, Mackenzie J, Roehrdanz P. Economic costs of achieving current conservation goals in the future as climate changes. Conserv Biol 2012; 26:385-396. [PMID: 22497365 DOI: 10.1111/j.1523-1739.2012.01824.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Conservation of biologically diverse regions has thus far been accomplished largely through the establishment and maintenance of protected areas. Climate change is expected to shift climate space of many species outside existing reserve boundaries. We used climate-envelope models to examine shifts in climate space of 11 species that are representative of the Mount Hamilton Project area (MHPA) (California, U.S.A.), which includes areas within Alameda, Santa Clara, San Joaquin, Stanislaus, Merced, and San Benito counties and is in the state's Central Coast ecoregion. We used Marxan site-selection software to determine the minimum area required as climate changes to achieve a baseline conservation goal equal to 80% of existing climate space for all species in the MHPA through 2050 and 2100. Additionally, we assessed the costs associated with use of existing conservation strategies (land acquisition and management actions such as species translocation, monitoring, and captive breeding) necessary to meet current species-conservation goals as climate changes. Meeting conservation goals as climate changes through 2050 required an additional 256,000 ha (332%) of protected area, primarily to the south and west of the MHPA. Through 2050 the total cost of land acquisition and management was estimated at US$1.67-1.79 billion, or 139-149% of the cost of achieving the same conservation goals with no climate change. To maintain 80% of climate space through 2100 required nearly 380,000 additional hectares that would cost $2.46-2.62 billion, or 209-219% of the cost of achieving the same conservation goals with no climate change. Furthermore, maintaining 80% of existing climate space within California for 27% of the focal species was not possible by 2100 because climate space for these species did not exist in the state. The high costs of conserving species as the climate changes-that we found in an assessment of one conservation project-highlights the need for tools that will aid in iterative goal setting given the uncertainty of the effects of climate change and adaptive management that includes new conservation strategies and consideration of the long-term economic costs of conservation.
Collapse
Affiliation(s)
- M Rebecca Shaw
- The Environmental Defense Fund, 123 Mission Street, San Francisco, CA 94105, USA. email
| | | | | | | | | |
Collapse
|
28
|
Wong SS, Haqshenas G, Gowans EJ, Mackenzie J. The dengue virus M protein localises to the endoplasmic reticulum and forms oligomers. FEBS Lett 2012; 586:1032-7. [DOI: 10.1016/j.febslet.2012.02.047] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2012] [Revised: 02/24/2012] [Accepted: 02/28/2012] [Indexed: 10/28/2022]
|
29
|
Mackenzie J, Law A, Kerr G, Higgins G, Howard G, Malik J, McLaren D. 7036 POSTER Improved Outcomes With Dose Escalated Hypofractionated Radiotherapy for Prostate Cancer. Eur J Cancer 2011. [DOI: 10.1016/s0959-8049(11)71987-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
30
|
Mackenzie J. A Defence of the Thesis THAT "THE OPPORTUNITIES OF THE GENERAL PRACTITIONER ARE ESSENTIAL FOR THE INVESTIGATION OF DISEASE AND THE PROGRESS OF MEDICINE.". Br Med J 2011; 1:797-804. [PMID: 20770319 DOI: 10.1136/bmj.1.3153.797] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
31
|
|
32
|
|
33
|
Mackenzie J. A Lecture ON THE SOLDIER'S HEART AND WAR NEUROSIS: A STUDY IN SYMPTOMATOLOGY: Delivered at the Clinical Institute, St. Andrews. Br Med J 2011; 1:491-4. [PMID: 20769853 DOI: 10.1136/bmj.1.3093.491] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
34
|
|
35
|
Mackenzie J. Remarks ON THE MEANING AND MECHANISM OF VISCERAL PAIN: AS SHOWN BY THE STUDY OF VISCERAL AND OTHER SYMPATHETIC (AUTONOMIC) REFLEXES. Br Med J 2011; 1:1449-54. [PMID: 20762739 DOI: 10.1136/bmj.1.2373.1449] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
36
|
Mackenzie J. Observations on the Inception of the Rhythm of the Heart by the Ventricle: As the cause of Continuous Irregularity of the Heart. Br Med J 2011; 1:529-36. [PMID: 20761393 DOI: 10.1136/bmj.1.2253.529] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
37
|
Mackenzie J. SOME MANIFESTATIONS OF A HEALTHY HEART IN THE YOUNG FREQUENTLY TAKEN AS INDICATIONS FOR TREATMENT. Br Med J 2011; 2:1697-700. [PMID: 20766441 DOI: 10.1136/bmj.2.2712.1697] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
38
|
|
39
|
|
40
|
|
41
|
|
42
|
|
43
|
Mackenzie J. Remarks on the Meaning and Mechanism of Visceral Pain as Shown by the Study of Visceral and other Sympathetic (Autonomic) Reflexes. Br Med J 2011; 1:1523-8. [PMID: 20762752 DOI: 10.1136/bmj.1.2374.1523] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
44
|
|
45
|
Lee AW, Farnquist B, Islam O, Mackenzie J, Taylor SAM, Pang SC, Reifel CW. Noninvasive investigation of asymmetrically conjoined tripus twins with features of rachipagus, parapagus dicephalus, and cephalopagus. Clin Anat 2011; 25:1023-9. [PMID: 21433086 DOI: 10.1002/ca.21149] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2010] [Revised: 01/17/2011] [Accepted: 01/18/2011] [Indexed: 11/09/2022]
Abstract
A hypothetical mechanism for conjoined twinning postulated by Spencer ([2003] Developmental Malformations and Clinical Implications, Baltimore: Johns Hopkins University Press, p 1-476) suggests that, after separation, monovular twins fuse in one of eight predictable homologous sites. The tripus fetal specimen under study embodies characteristics of three types therefore preventing it from classification into a simple variant of any one of the eight twin types described by Spencer. The aim of this study was to reveal internal structural anomalies of the fetal specimen by using magnetic resonance imaging and computerized tomography. Dorsally appended to the primary twin is a secondary head mass (brain tissue and ocular globe) and two spinal columns converging at T4/T5, suggesting rachipagus twinning. The ventral orientation of the secondary twin's (right lateral) lower limb suggests parapagus twinning. The caudal divergence of the spinal columns and the presence of a secondary hemipelvis, separate from the primary pelvis, suggest cephalopagus twinning. Measurements of the long bones indicate a gestational age of ∼20-23 weeks. Secondary malformations of the primary fetal body include anencephaly, cleft palate, renal agenesis, decreased left ventricular outflow, and a prematurely terminating descending aorta. This study demonstrates the possibility of using current imaging techniques to study very old, formalin-preserved human material for documentation and scientific discussion without destroying the specimen, thus keeping it intact for posterity.
Collapse
Affiliation(s)
- A W Lee
- Department of Anatomy and Cell Biology, Queen's University, Kingston, Ontario, Canada
| | | | | | | | | | | | | |
Collapse
|
46
|
Srinivasan J, Hand S, Lidstone S, Vafai N, Mackenzie J, Gavinio J, Mak E, Schulzer M, Stoessl A. P1.214 Uncertainty vs. likelihood of reward: implications for the placebo effect in Parkinson's disease. Parkinsonism Relat Disord 2009. [DOI: 10.1016/s1353-8020(09)70336-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
47
|
Szvetko AL, Jones A, Mackenzie J, Tajouri L, Csurhes PA, Greer JM, Pender MP, Griffiths LR. An investigation of the C77G and C772T variations within the human protein tyrosine phosphatase receptor type C gene for association with multiple sclerosis in an Australian population. Brain Res 2009; 1255:148-52. [DOI: 10.1016/j.brainres.2008.12.017] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2008] [Revised: 12/08/2008] [Accepted: 12/09/2008] [Indexed: 01/12/2023]
|
48
|
Muhle H, Bellmann B, Creutzenberg O, Fuhst R, Koch W, Mohr U, Takenaka S, Morrow P, Kilpper R, Mackenzie J, Mermelstein R. Subchronic Inhalation Study of Toner in Rats. Inhal Toxicol 2008. [DOI: 10.3109/08958379009145262] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
49
|
Tong S, Mackenzie J, Pitman AJ, FitzGerald G, Nicholls N, Selvey L. Global climate change: time to mainstream health risks and their prevention on the medical research and policy agenda. Intern Med J 2008; 38:445-7. [DOI: 10.1111/j.1445-5994.2008.01688.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
50
|
Brem MH, Schlechtweg PM, Mackenzie J, Winalski CS, Lang P. [Molecular imaging: future uses in arthritides]. Radiologe 2007; 46:394-402. [PMID: 16715224 DOI: 10.1007/s00117-006-1373-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
Molecular imaging is an upcoming field in radiology as a result of great advances in imaging technology, genetics, and biochemistry in the recent past. Early-stage imaging of molecular pathological changes in cells opens the gates to new methods in medical treatment of diseases that otherwise would only be detected in advanced stages. Methods of imaging biochemical pathways with molecular agents are currently an issue of intensive research. This article reviews current modalities of molecular imaging in arthritis that should offer future perspective on early disease detection, diagnosis, and monitoring of treatment efficiency and how they can pave the way to optimized therapy.
Collapse
Affiliation(s)
- M H Brem
- Department of Radiology, Brigham and Women's Hospital of Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
| | | | | | | | | |
Collapse
|